Figure 2
Number of patients grouped on the basis of IFX levels, detected by ELISA or SPR. N.d. indicates levels below the limit of detection (0.25 μg mL−1), and 3–7 (μg mL−1) indicates the therapeutic range.
Figure 2 | Scientific Reports
Number of patients grouped on the basis of IFX levels, detected by ELISA or SPR. N.d. indicates levels below the limit of detection (0.25 μg mL−1), and 3–7 (μg mL−1) indicates the therapeutic range.
